Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Decode Slide 7.7 Percent on Q4 Revenue Decline, Widened Loss

NEW YORK, March 7(GenomeWeb News) - Shares in Decode Genetics were down 7.74 percent, or $.73 at $8.70 in mid-afternoon trading after the company yesterday reported an approximately 13-percent decrease in revenues amid escalating losses for the fourth quarter.

 

As GenomeWeb News reported this morning, Decode's revenues for the three months ended Dec.31, 2005, dropped to $9.8 million from $11.2 million year over year, while losses grew to $21.1 million from $19.4 million in the year-ago period.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.